ZEISS Parallel Industry Session
EGS 15th Congress
ZEISS Glaucoma workflow innovation from diagnostic to therapy
Agenda
- Panel discussion
- Integrated digital workflow in glaucoma - novel methodologies
- Value of progression analysis for long term patient management and decision for the timely and appropriate treatment
- Experience with ZEISS SLT as adjunctive therapy - study results
ZEISS Parallel Industry Session
![]({"xsmall":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original.image_file.100.100.file/gus_gazzard.jpg","small":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg","medium":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg","large":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg","xlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg","xxlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg","max":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/gus_gazzard.jpg/_jcr_content/renditions/original./gus_gazzard.jpg"})
Prof. Gus Gazzard
Panel Discussion
Director of the Glaucoma Service at Moorfields Eye Hospital, UK; Professor of Ophthalmology, Glaucoma Studies at UCL London, UK; Consultant Ophthalmic Surgeon and Chief Investigator of the LiGHT Trial
![]({"xsmall":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.100.100.file/marta-pazos.jpg","small":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.360.360.file/marta-pazos.jpg","medium":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.768.768.file/marta-pazos.jpg","large":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.1024.1024.file/marta-pazos.jpg","xlarge":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.1280.1280.file/marta-pazos.jpg","xxlarge":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original.image_file.1440.1440.file/marta-pazos.jpg","max":"https://www.zeiss.com/content/dam/z/med/reference-master/myzeiss/peer-insights/free/ophthalmic-diagnostics/1003-what-role-does-the-macula-play-in-glaucoma-management/marta-pazos.jpg/_jcr_content/renditions/original./marta-pazos.jpg"})
Dr. Marta Pazos, MD, PhD
Integrated digital workflow in glaucoma - novel methodologies
Glaucoma Consultant, Hospital Clínic de Barcelona, Barcelona, Spain; Researcher, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Spain
![]({"xsmall":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original.image_file.100.100.file/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","small":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original.image_file.360.360.file/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","medium":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original./doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","large":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original./doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","xlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original./doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","xxlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original./doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg","max":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg/_jcr_content/renditions/original./doctora-pilar-de-clinica-oftalmologica-fernandez-casas.jpg"})
Dr. Pilar Casas de Llera, MD, PhD
Value of progression analysis for long term patient management and decision for the timely and appropriate treatment
Consultant Ophthalmic Surgeon, Glaucoma Specialist, Fernández Casas Oftalmólogos Torrelavega, Cantabria, Spain
![]({"xsmall":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.100.100.218,174,772,728.file/klabe.jpg","small":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.360.360.218,174,772,728.file/klabe.jpg","medium":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.554.554.218,174,772,728.file/klabe.jpg","large":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.554.554.218,174,772,728.file/klabe.jpg","xlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.554.554.218,174,772,728.file/klabe.jpg","xxlarge":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.554.554.218,174,772,728.file/klabe.jpg","max":"https://www.zeiss.com/content/dam/z/med/international/campaigns/25-years-of-glaucoma-innovation/klabe.jpg/_jcr_content/renditions/original.image_file.554.554.218,174,772,728.file/klabe.jpg"})
Dr. Karsten Klabe
Experience with ZEISS SLT as adjunctive therapy - study results
Head surgeon, Breyer, Kaymak & Klabe Augenchirurgie, Düsseldorf, Germany; Co-operation partner, International Vision Correction Research Venter Networks (IVCR.net), Universitäts-Augenklinik, Heidelberg, Germany; Head of the Research Institute for International Innovative Ophthalmologic Surgery (I.I.O.), Düsseldorf, Germany